|
(V540) |
Genetic determinants controlling lipid deposits in different zebrafish (Danio rerio) strains |
| |
|
K. Vishnolia, K. Tarhbalouti, P. Ciba, C. Kruse, Z. Aherrahrou, J. Erdmann (Lübeck) |
|
|
Diskussion |
|
(V541) |
SDF1 polymorphisms influence outcome in patients with symptomatic cardiovascular disease |
| |
|
D. Rath, E. Schäffeler, S. Winter, J. Hewer, K. A. L. Müller, M. Droppa, F. Stimpfle, M. Gawaz, M. Schwab, T. Geisler (Tübingen, Stuttgart) |
|
|
Diskussion |
|
(V542) |
The gut hormone Glucagon like peptide 1 (GLP-1) is increased in response to myocardial infarction and improves left ventricular function in a GLP-1 receptor dependent manner |
| |
|
S. Diebold, J. Möllmann, F. Kahles, C. Lebherz, N. Marx, M. Lehrke (Aachen) |
|
|
Diskussion |
|
(V543) |
High plasma levels of Gremlin-1 and Macrophage Migration Inhibitory Factor but not their ratio indicate an increased risk for acute coronary syndrome in patients with type 2 diabetes mellitus |
| |
|
K. A. L. Müller, D. Rath, M. Schmid, H. Schoenleber, M. Gawaz, T. Geisler, I. I. Müller (Tübingen) |
|
|
Diskussion |
|
(V544) |
Hoher prädiktiver Wert der Biomarker TIMP-2 und IGFBP-7 zur frühzeitigen Detektion einer akuten Nierenfunktionsstörung nach kardiopulmonaler Reanimation |
| |
|
C. Adler, F. Schregel, T. Heller, S. Grönke, H. Reuter (Köln) |
|
|
Diskussion |
|
(V545) |
Improvement of LDL-Cholesterol Goal Attainment in High-Risk-Patients in Europe and Middle East Between 2008/09 and 2013/14: Results Of DYSIS And DYSIS II CHD |
| |
|
A. K. Gitt, D. Horack, D. Lautsch, B. M. Ambegaonkar, J. Ferrieres , DYSIS Investigators (Ludwigshafen; Wien, AT; Kenilworth, US; Toulouse, FR) |
|
|
Diskussion |